How to Develop and Implement a National Drug Policy - WHO Policy Perspectives on Medicines, No. 006, January 2003
(2003; 6 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentWhat is a national drug policy?
Afficher le documentObjectives of a national drug policy
Afficher le documentThe essential medicine concept is central to a national drug policy
Afficher le documentThe national drug policy process
Fermer ce répertoireKey components of a national drug policy
Afficher le documentSelection of essential medicines
Afficher le documentAffordability
Afficher le documentFinancing options
Afficher le documentSupply systems
Afficher le documentRegulation and quality assurance
Afficher le documentRational use
Afficher le documentResearch
Afficher le documentHuman resources development
Afficher le documentMonitoring and evaluation
Afficher le documentKey documents
 

Supply systems

Another essential component is a reliable supply system. Various types of supply systems exist which vary considerably with respect to the role of the private sector and the incentives for efficiency. But whatever system is developed, its aim is to ensure continued availability of essential medicines with low rates of stock-outs and low costs of medicines. Key policy issues are to:

• promoting a public-private mix in medicine supply and distribution systems;

• commiting to good pharmaceutical procurement practices in the public sector;

• publishing price information on raw materials and finished products;

• ensuring medicine supply systems in acute emergencies;

• carrying out inventory control, and taking measures for prevention of theft and waste;

• ensuring disposal of unwanted or expired medicines.

 

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013